GHRL and metabolic syndrome: In the current study, the ratio of obestatin/UnAG was significantly higher in subjects with the cluster of four MetS risk factors compared to subjects without the cluster of four MetS risk factors by 4-fold (p = 0.001) (Fig. 2A).